Optimer Pharmaceuticals, Inc. News, Optimer Pharmaceuticals, Inc. Quote, OPTR Quote

Optimer Pharmaceuticals, Inc. (NQ:OPTR) Delayed: 14.33 -0.11 (0.76%)
Previous Close	$14.44	52 Week High	$16.80
Open	$14.45	52 Week Low	$8.64
Day High	$14.61	P/E	N/A
Day Low	$14.25	EPS	$-1.20
Volume	8,800

Friends, Peers and Foes (?): CBST, AZN, ALPM GSK (more...)

ALERTS | RSS

May 24, 2013 04:25 PM Form SC 13G OPTIMER PHARMACEUTICALS Filed by: Flynn James E
May 17, 2013 07:29 PM Form 4 OPTIMER PHARMACEUTICALS For: May 15 Filed by: Schaum Meredith
May 15, 2013 03:52 PM Cubist (CBST) Said to Bid $1B for Optimer (OPTR) Before Sales Proceeds - Reuters
May 13, 2013 09:37 PM Form 4 OPTIMER PHARMACEUTICALS For: May 09 Filed by: Sirota Eric
May 13, 2013 05:16 PM Market Wrap: Retail Sales Rip in April; Theravance, Elan Enter $1B Deal; Petrobras' Record Debt Sale
May 13, 2013 05:13 PM Form 8-K OPTIMER PHARMACEUTICALS For: May 13
May 13, 2013 04:05 PM Optimer (OPTR) Names Eric Sirota as COO
May 13, 2013 04:04 PM Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
May 13, 2013 03:57 PM Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
May 10, 2013 07:59 AM Baird Downgrades Optimer Pharmaceuticals (OPTR) to Neutral

Entities mentioned with OPTR

View All Entities